caseins has been researched along with rosiglitazone in 3 studies
| Studies (caseins) | Trials (caseins) | Recent Studies (post-2010) (caseins) | Studies (rosiglitazone) | Trials (rosiglitazone) | Recent Studies (post-2010) (rosiglitazone) |
|---|---|---|---|---|---|
| 16,863 | 561 | 4,170 | 4,749 | 556 | 1,818 |
| Protein | Taxonomy | caseins (IC50) | rosiglitazone (IC50) |
|---|---|---|---|
| CDGSH iron-sulfur domain-containing protein 1 | Rattus norvegicus (Norway rat) | 1.1 | |
| Bile salt export pump | Homo sapiens (human) | 4.5853 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 4.069 | |
| Peroxisome proliferator-activated receptor alpha | Mus musculus (house mouse) | 0.08 | |
| Thromboxane-A synthase | Homo sapiens (human) | 3.56 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.832 | |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.2481 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.038 | |
| ATP-binding cassette sub-family C member 8 | Homo sapiens (human) | 0.048 | |
| ATP-sensitive inward rectifier potassium channel 11 | Homo sapiens (human) | 0.048 | |
| Sodium/bile acid cotransporter | Homo sapiens (human) | 5.1 | |
| CDGSH iron-sulfur domain-containing protein 2 | Homo sapiens (human) | 2.29 | |
| CDGSH iron-sulfur domain-containing protein 1 | Homo sapiens (human) | 0.731 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banz, WJ; Davis, J; Iqbal, MJ; Peterson, R | 1 |
| Adler, S; Banz, W; Cho, KW; Davis, J; Higginbotham, A; Kim, YC; Moustaid-Moussa, N; O'Connor, T; Peterson, R; Shay, N; Tebbe, A | 1 |
| Cha, BS; Huh, JH; Kang, ES; Kang, SB; Kim, HJ; Kim, HM; Lee, BW; Lee, HC; Seok, H | 1 |
3 other study(ies) available for caseins and rosiglitazone
| Article | Year |
|---|---|
Gene expression and adiposity are modified by soy protein in male Zucker diabetic fatty rats.
Topics: Adipose Tissue; Animals; Body Composition; Caseins; Diabetes Mellitus; Diet; Dietary Proteins; Gene Expression; Hypoglycemic Agents; Isoflavones; Lipids; Liver; Male; Obesity; Organ Size; Polymerase Chain Reaction; Rats; Rats, Zucker; RNA, Messenger; Rosiglitazone; Soybean Proteins; Thiazolidinediones | 2004 |
Soy protein and isoflavones influence adiposity and development of metabolic syndrome in the obese male ZDF rat.
Topics: Adiposity; Animals; Blood Glucose; Caseins; Hypoglycemic Agents; Isoflavones; Kidney Diseases; Liver; Male; Metabolic Syndrome; Milk Proteins; Obesity; Proteinuria; Rats; Rats, Inbred Strains; Rosiglitazone; Soybean Proteins; Thiazolidinediones | 2007 |
Rosiglitazone attenuates casein-induced hepatic endoplasmic reticulum stress in Sprague-Dawley rats: a novel model of endoplasmic reticulum stress.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Body Weight; Caseins; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Endoplasmic Reticulum Stress; Inflammation; Liver; Male; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones | 2013 |